{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:57Z","timestamp":1791295617095,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Moyamoya disease (MMD) is a rare disorder characterized by cerebrovascular occlusion and development of hemorrhage-prone collateral vessels. Approximately 10\u201312% of cases are familial, with a presumed low penetrance autosomal dominant pattern of inheritance. Diagnosis commonly occurs only after clinical presentation. The recent identification of the RNF213 founder mutation (p.R4810K) in the Asian population has made a significant contribution, but the etiology of this disease remains unclear. To further develop the variant landscape of MMD, we performed high-depth whole exome sequencing of 125 unrelated, predominantly nonfamilial, ethnically diverse MMD patients in parallel with 125 internally sequenced, matched controls using the same exome and analysis platform. Three subpopulations were established: Asian, Caucasian, and non-RNF213 founder mutation cases. We provided additional support for the previously observed RNF213 founder mutation (p.R4810K) in Asian cases (P = 6.01\u00d710\u22125) that was enriched among East Asians compared to Southeast Asian and Pacific Islander cases (P = 9.52\u00d710\u22124) and was absent in all Caucasian cases. The most enriched variant in Caucasian (P = 7.93\u00d710\u22124) and non-RNF213 founder mutation (P = 1.51\u00d710\u22123) cases was ZXDC (p.P562L), a gene involved in MHC Class II activation. Collapsing variant methodology ranked OBSCN, a gene involved in myofibrillogenesis, as most enriched in Caucasian (P = 1.07\u00d710\u22124) and non-RNF213 founder mutation cases (P = 5.31\u00d710\u22125). These findings further support the East Asian origins of the RNF213 (p.R4810K) variant and more fully describe the genetic landscape of multiethnic MMD, revealing novel, alternative candidate variants and genes that may be important in MMD etiology and diagnosis.<\/jats:p>","DOI":"10.1534\/g3.115.020321","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T23:20:10Z","timestamp":1447197610000},"page":"41-49","source":"Crossref","is-referenced-by-count":49,"title":["Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing"],"prefix":"10.1093","volume":"6","author":[{"given":"Lorelei D","family":"Shoemaker","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University, Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Clark","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Patwardhan","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Chandratillake","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Garcia","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A","family":"Morgan","sequence":"additional","affiliation":[{"name":"Stanford Medical School, Stanford University, Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Leng","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kirk","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chen","sequence":"additional","affiliation":[{"name":"Personalis Inc., Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J","family":"Cook","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience Studies and the Department of Surgery, Queen's University, Kingston, Ontario, K7L 3N6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Snyder","sequence":"additional","affiliation":[{"name":"Department of Genetics, Stanford University, Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University, Stanford, California 94305"},{"name":"Department of Neurosurgery and Stanford Stroke Center, Stanford University, Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"2021062506132829500_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molimm.2006.02.029","article-title":"ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription.","volume":"44","author":"Al-Kandari","year":"2007","journal-title":"Mol. Immunol."},{"key":"2021062506132829500_bib2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","article-title":"Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease.","volume":"44","author":"Bower","year":"2013","journal-title":"Stroke"},{"key":"2021062506132829500_bib3","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","article-title":"RNF213 rare variants in an ethnically diverse population with moyamoya disease.","volume":"45","author":"Cecchi","year":"2014","journal-title":"Stroke"},{"key":"2021062506132829500_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","article-title":"Moyamoya disease in China: its clinical features and outcomes.","volume":"43","author":"Duan","year":"2012","journal-title":"Stroke"},{"key":"2021062506132829500_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","article-title":"Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene.","volume":"16","author":"Fujimura","year":"2014","journal-title":"J. Stroke"},{"key":"2021062506132829500_bib6","first-page":"49","article-title":"Moyamoya disease and syndromes: from genetics to clinical management.","volume":"8","author":"Guey","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"2021062506132829500_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","article-title":"Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease.","volume":"84","author":"Guo","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"2021062506132829500_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.clineuro.2012.09.020","article-title":"An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.","volume":"115","author":"Hayashi","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2021062506132829500_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","article-title":"Downregulation of securin by the variant RNF213 R4810K reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.","volume":"438","author":"Hitomi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021062506132829500_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2013.08.067","article-title":"The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.","volume":"439","author":"Hitomi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021062506132829500_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2176\/nmc.52.267","article-title":"Review of past research and current concepts on the etiology of moyamoya disease.","volume":"52","author":"Houkin","year":"2012","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"2021062506132829500_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/302243","article-title":"Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.","volume":"64","author":"Ikeda","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"2021062506132829500_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/088307380001500307","article-title":"Linkage analysis of moyamoya disease on chromosome 6.","volume":"15","author":"Inoue","year":"2000","journal-title":"J. Child Neurol."},{"key":"2021062506132829500_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.brainres.2014.11.014","article-title":"Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.","volume":"1594","author":"Ito","year":"2015","journal-title":"Brain Res."},{"key":"2021062506132829500_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first moyamoya disease gene.","volume":"56","author":"Kamada","year":"2011","journal-title":"J. Hum. Genet."},{"key":"2021062506132829500_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1227\/NEU.0b013e3182600b3c","article-title":"Sex differences in clinical presentation and treatment outcomes in moyamoya disease.","volume":"71","author":"Khan","year":"2012","journal-title":"Neurosurgery"},{"key":"2021062506132829500_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2013.02.015","article-title":"Ablation of RNF213 retards progression of diabetes in the Akita mouse.","volume":"432","author":"Kobayashi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021062506132829500_bib18","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya disease in Europeans.","volume":"39","author":"Kraemer","year":"2008","journal-title":"Stroke"},{"key":"2021062506132829500_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","article-title":"Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.","volume":"39","author":"Kuriyama","year":"2008","journal-title":"Stroke"},{"key":"2021062506132829500_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajhg.2008.06.024","article-title":"Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data.","volume":"83","author":"Li","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"2021062506132829500_bib21","doi-asserted-by":"crossref","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"2021062506132829500_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2176\/nmc.52.299","article-title":"Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in east and southeast Asian populations.","volume":"52","author":"Liu","year":"2012","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"2021062506132829500_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12041-013-0304-5","article-title":"Genomewide association study identifies no major founder variant in Caucasian moyamoya disease.","volume":"92","author":"Liu","year":"2013","journal-title":"J. Genet."},{"issue":"24 Pt 2","key":"2021062506132829500_bib24","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","article-title":"Autosomal dominant moyamoya disease maps to chromosome 17q25.3.","volume":"70","author":"Mineharu","year":"2008","journal-title":"Neurology"},{"key":"2021062506132829500_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","article-title":"Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.","volume":"88","author":"Miskinyte","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"2021062506132829500_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","article-title":"Homozygous c.14576G&gt;A variant of RNF213 predicts early-onset and severe form of moyamoya disease.","volume":"78","author":"Miyatake","year":"2012","journal-title":"Neurology"},{"key":"2021062506132829500_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000250095","article-title":"Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.","volume":"47","author":"Orr","year":"2010","journal-title":"J. Vasc. Res."},{"key":"2021062506132829500_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/iub.1157","article-title":"Obscurins: unassuming giants enter the spotlight.","volume":"65","author":"Perry","year":"2013","journal-title":"IUBMB Life"},{"key":"2021062506132829500_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpn.2010.09.002","article-title":"Analysis of ACTA2 in European moyamoya disease patients.","volume":"15","author":"Roder","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"2021062506132829500_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","article-title":"A novel susceptibility locus for moyamoya disease on chromosome 8q23.","volume":"49","author":"Sakurai","year":"2004","journal-title":"J. Hum. Genet."},{"key":"2021062506132829500_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrg3051","article-title":"Understanding the contribution of synonymous mutations to human disease.","volume":"12","author":"Sauna","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"2021062506132829500_bib32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome.","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021062506132829500_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/jhg.2009.91","article-title":"ACTA2 is not a major disease-causing gene for moyamoya disease.","volume":"54","author":"Shimojima","year":"2009","journal-title":"J. Hum. Genet."},{"key":"2021062506132829500_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1172-8-45","article-title":"Immune response profiling identifies autoantibodies specific to moyamoya patients.","volume":"8","author":"Sigdel","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"2021062506132829500_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1227\/NEU.0b013e318253ab8e","article-title":"Moyamoya disorder in the United States.","volume":"71","author":"Starke","year":"2012","journal-title":"Neurosurgery"},{"key":"2021062506132829500_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates.","volume":"64","author":"Storey","year":"2002","journal-title":"J. R. Stat. Soc. Series B Stat. Methodol."},{"key":"2021062506132829500_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain.","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch. Neurol."},{"key":"2021062506132829500_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.1219240","article-title":"Evolution and functional impact of rare coding variation from deep sequencing of human exomes.","volume":"337","author":"Tennessen","year":"2012","journal-title":"Science"},{"key":"2021062506132829500_bib39","year":"2012"},{"key":"2021062506132829500_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","article-title":"Moyamoya disease in Washington State and California.","volume":"65","author":"Uchino","year":"2005","journal-title":"Neurology"},{"key":"2021062506132829500_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005792-200111000-00006","article-title":"MHC class II deficiency: a disease of gene regulation.","volume":"80","author":"Villard","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"2021062506132829500_bib42","doi-asserted-by":"crossref","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","article-title":"Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"2021062506132829500_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.STR.14.1.50","article-title":"Histopathology of the brain vascular network in moyamoya disease.","volume":"14","author":"Yamashita","year":"1983","journal-title":"Stroke"},{"key":"2021062506132829500_bib44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/01.STR.31.4.930","article-title":"Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.","volume":"31","author":"Yamauchi","year":"2000","journal-title":"Stroke"}],"container-title":["G3 Genes|Genomes|Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/g3journal\/article-pdf\/6\/1\/41\/38823405\/g3journal0041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/g3journal\/article-pdf\/6\/1\/41\/38823405\/g3journal0041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T06:13:58Z","timestamp":1624601638000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/g3journal\/article\/6\/1\/41\/6027355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.1534\/g3.115.020321","relation":{},"ISSN":["2160-1836"],"issn-type":[{"value":"2160-1836","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2016,1,1]]}}}